Fort Washington Investment Advisors Inc. OH Has $30.49 Million Stock Position in Encompass Health Co. (NYSE:EHC)

Fort Washington Investment Advisors Inc. OH cut its holdings in shares of Encompass Health Co. (NYSE:EHC) by 0.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 301,022 shares of the company’s stock after selling 1,250 shares during the period. Fort Washington Investment Advisors Inc. OH’s holdings in Encompass Health were worth $30,488,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. US Bancorp DE lifted its holdings in Encompass Health by 9.6% during the fourth quarter. US Bancorp DE now owns 1,380 shares of the company’s stock valued at $127,000 after purchasing an additional 121 shares during the last quarter. Signaturefd LLC increased its stake in shares of Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company’s stock worth $65,000 after acquiring an additional 125 shares in the last quarter. CBIZ Investment Advisory Services LLC boosted its stake in Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after purchasing an additional 127 shares in the last quarter. CIBC Asset Management Inc lifted its stake in Encompass Health by 5.2% during the 4th quarter. CIBC Asset Management Inc now owns 3,111 shares of the company’s stock valued at $287,000 after acquiring an additional 154 shares during the period. Finally, SPC Financial Inc. increased its position in shares of Encompass Health by 0.3% during the 4th quarter. SPC Financial Inc. now owns 45,077 shares of the company’s stock valued at $4,163,000 after purchasing an additional 154 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Stock Performance

Shares of NYSE:EHC opened at $119.21 on Thursday. The business’s 50-day simple moving average is $113.09 and its 200 day simple moving average is $103.15. Encompass Health Co. has a one year low of $82.74 and a one year high of $123.13. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The company has a market cap of $12.02 billion, a P/E ratio of 26.73, a PEG ratio of 2.31 and a beta of 0.89.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating analysts’ consensus estimates of $1.19 by $0.18. The company had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Encompass Health’s quarterly revenue was up 10.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.12 earnings per share. On average, sell-side analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.57%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health’s payout ratio is 14.05%.

Insider Buying and Selling

In other Encompass Health news, insider Elissa Joy Charbonneau sold 4,279 shares of the stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total transaction of $498,974.19. Following the completion of the transaction, the insider now directly owns 11,958 shares in the company, valued at $1,394,422.38. This represents a 26.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP John Patrick Darby sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the sale, the executive vice president now directly owns 79,710 shares of the company’s stock, valued at approximately $9,149,910.90. The trade was a 11.15% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 132,663 shares of company stock worth $16,034,082. Corporate insiders own 2.00% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have issued reports on EHC. Truist Financial restated a “buy” rating and set a $135.00 price objective (up from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. Royal Bank of Canada increased their price target on Encompass Health from $110.00 to $125.00 and gave the stock an “outperform” rating in a research report on Monday, April 28th. Barclays upped their target price on Encompass Health from $118.00 to $129.00 and gave the stock an “overweight” rating in a report on Friday, April 25th. KeyCorp boosted their price objective on shares of Encompass Health from $122.00 to $135.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 27th. Finally, UBS Group increased their price objective on shares of Encompass Health from $117.00 to $130.00 and gave the company a “buy” rating in a research report on Monday, April 28th. Eight research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $127.00.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.